Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Highlights from the 12th Annual ASH Scientific Meeting

June 13, 1997

KW-3902 may be beneficial in hemorrhagic shock

June 13, 1997

Mylan files ANDA for generic nifedipine

June 12, 1997

Midodrine efficacy in diabetic patients with orthostatic hypotension

June 11, 1997

SR-BI receptor implicated in HDL metabolism

June 11, 1997

Eclipse cleared by FDA to begin clinical trials of PTMR

June 10, 1997

Pfizer terminates E5 marketing agreement

June 10, 1997

IVIg for acute cardiomyopathy

June 9, 1997

New C5a antagonist discovered by Rhone-Poulenc Rorer

June 4, 1997

NEP/ACE/ECE inhibitors described by Wakamoto

June 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...